← Alle mensen

EP

Elvire Pons-Tostivint

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Corrigendum: DESTINY-Lung02 eindanalyse en patiëntgerapporteerde uitkomsten

Journal of Thoracic Oncology · 23 februari 2026

PD-1-blokkade versterkt geen allo-immunisatie na allogene dendritische celvaccinatie

Frontiers in immunology · 2026

Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02-A Dose-Blinded, Gerandomiseerde, Phase 2 Stu...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-12

A Pooled Analysis of Datopotamab Deruxtecan in Patiënten met EGFR-Mutated NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-11

Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as Eerstelijns Therapy for Metastatic Nonsquamous NSCLC: Ph...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-09

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Gevorderd or Metastatic Non-Small Cell Lung Cancer: Th...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2025

Trastuzumab deruxtecan bij HER2-gemuteerd gemetastaseerd NSCLC: DESTINY-Lung02 primaire resultaten

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 november 2023